1. Home
  2. MLP vs CERS Comparison

MLP vs CERS Comparison

Compare MLP & CERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MLP

Maui Land & Pineapple Company Inc.

N/A

Current Price

$16.09

Market Cap

338.2M

Sector

Finance

ML Signal

N/A

Logo Cerus Corporation

CERS

Cerus Corporation

N/A

Current Price

$1.79

Market Cap

276.0M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
MLP
CERS
Founded
1909
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate
EDP Services
Sector
Finance
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
338.2M
276.0M
IPO Year
2010
1996

Fundamental Metrics

Financial Performance
Metric
MLP
CERS
Price
$16.09
$1.79
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
17.3K
1.6M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
27.27
EPS
N/A
N/A
Revenue
$11,565,000.00
$51,326,000.00
Revenue This Year
N/A
$20.00
Revenue Next Year
N/A
$9.60
P/E Ratio
N/A
N/A
Revenue Growth
5.96
30.68
52 Week Low
$13.84
$1.12
52 Week High
$20.34
$2.96

Technical Indicators

Market Signals
Indicator
MLP
CERS
Relative Strength Index (RSI) 36.81 32.71
Support Level $15.75 $1.27
Resistance Level $17.43 $2.26
Average True Range (ATR) 0.35 0.17
MACD -0.08 -0.08
Stochastic Oscillator 6.25 5.24

Price Performance

Historical Comparison
MLP
CERS

About MLP Maui Land & Pineapple Company Inc.

Maui Land & Pineapple Co Inc is a landholding and operating company. ML&P owns, develops, sells, and manages residential, resort, commercial, agricultural, and industrial real estate. It operates in three segments: Land Development & Sales which includes land planning and entitlement, development, and sales activities; Leasing operations include residential, resort, commercial, agricultural, industrial land and property leases; and Resort Amenities segment, which include a membership program that provides certain benefits and privileges within the Kapalua Resort for its members. The majority of its revenue is derived from the Leasing segment. Leasing revenue is generated from restaurants, retail outlets, office buildings, warehouses, and other resort activities.

About CERS Cerus Corporation

Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.

Share on Social Networks: